AGIO
Agios Pharmaceuticals Inc

2,880
Mkt Cap
$2.02B
Volume
1.18M
52W High
$46.00
52W Low
$22.24
PE Ratio
-3.92
AGIO Fundamentals
Price
$26.85
Prev Close
$27.27
Open
$27.60
50D MA
$36.99
Beta
1.15
Avg. Volume
2.4M
EPS (Annual)
$11.64
P/B
1.24
Rev/Employee
$74,790.98
Loading...
Loading...
News
all
press releases
Frazier Life Sciences Management L.P. Increases Stock Position in Agios Pharmaceuticals, Inc. $AGIO
Frazier Life Sciences Management L.P. raised its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 19.6% in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Agios Pharmaceuticals, Inc. $AGIO Shares Purchased by Bellevue Group AG
Bellevue Group AG raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·3d ago
News Placeholder
Armistice Capital LLC Has $38.85 Million Holdings in Agios Pharmaceuticals, Inc. $AGIO
Armistice Capital LLC decreased its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 43.0% in the 2nd quarter, according to its most recent 13F filing with the SEC...
MarketBeat·4d ago
News Placeholder
Agios Awaits Pyrukynd Decision in Thalassemia as FDA Misses Due Date
AGIO faces uncertainty as the FDA misses its Dec. 7 deadline related to the sNDA for Pyrukynd in thalassemia and offers no new timeline.
Zacks·6d ago
News Placeholder
Marshall Wace LLP Purchases 163,796 Shares of Agios Pharmaceuticals, Inc. $AGIO
Marshall Wace LLP boosted its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 31.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·7d ago
News Placeholder
Futures Rise For 10th Day In Past 11 With Fed Rate Cut Looming
Futures Rise For 10th Day In Past 11 With Fed Rate Cut Looming With just 17 trading sessions left in 2025, stock futures edge higher again and are on pace for 10 gains in the past 11 days. S&P 500...
Zero Hedge·7d ago
News Placeholder
Prudential Financial Inc. Lowers Holdings in Agios Pharmaceuticals, Inc. $AGIO
Prudential Financial Inc. reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 22.5% in the 2nd quarter, according to the company in its most recent disclosure...
MarketBeat·14d ago
News Placeholder
Envestnet Asset Management Inc. Reduces Holdings in Agios Pharmaceuticals, Inc. $AGIO
Envestnet Asset Management Inc. lowered its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 55.2% in the second quarter, according to its most recent filing with the...
MarketBeat·17d ago
News Placeholder
FY2026 EPS Estimates for AGIO Increased by Cantor Fitzgerald
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Analysts at Cantor Fitzgerald increased their FY2026 earnings per share estimates for Agios Pharmaceuticals in a research note issued on...
MarketBeat·17d ago
News Placeholder
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the...
MarketBeat·19d ago
<
1
2
...
>

Latest AGIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.